This report aims to provide a comprehensive presentation of the global market for Cancer Genome Analysis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Genome Analysis. This report contains market size and forecasts of Cancer Genome Analysis in global, including the following market information:
Global Cancer Genome Analysis Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Genome Analysis market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Solid Tissue Analysis Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Genome Analysis include Abbott Diagnostics, AccuraGen Inc, Acuamark Diagnostics, Admera Health, LLC, Agena Bioscience, Inc, Agilent, Almac Diagnostics, Amoy Diagnostics Co., Ltd. and Anchor Dx, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Genome Analysis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Genome Analysis Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Cancer Genome Analysis Market Segment Percentages, by Type, 2022 (%)
Solid Tissue Analysis
Liquid Tissue Analysis
Global Cancer Genome Analysis Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Cancer Genome Analysis Market Segment Percentages, by Application, 2022 (%)
Clinical
Pharmaceutical
Research
Global Cancer Genome Analysis Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Cancer Genome Analysis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Genome Analysis revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Genome Analysis revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Diagnostics
AccuraGen Inc
Acuamark Diagnostics
Admera Health, LLC
Agena Bioscience, Inc
Agilent
Almac Diagnostics
Amoy Diagnostics Co., Ltd.
Anchor Dx
ANGLE plc
ApoCell, Inc.
ArcherDx, Inc
Asuragen
AVIVA Biosciences
Baylor Miraca Genetics Laboratories
Beckman Coulter, Inc.
Becton, Dickinson and Company
BGI Genomics Co. Ltd
Bioarray Genetics
Biocartis
Biocept, Inc
Biodesix Inc
BioFluidica
bioM?rieux Diagnostics
Bioneer Corporation
Bio-Rad Laboratories, Inc
Bio-Techne
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Genome Analysis, market overview.
Chapter 2: Global Cancer Genome Analysis market size in revenue.
Chapter 3: Detailed analysis of Cancer Genome Analysis company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Genome Analysis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Genome Analysis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Genome Analysis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Genome Analysis Overall Market Size
2.1 Global Cancer Genome Analysis Market Size: 2022 VS 2030
2.2 Global Cancer Genome Analysis Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Genome Analysis Players in Global Market
3.2 Top Global Cancer Genome Analysis Companies Ranked by Revenue
3.3 Global Cancer Genome Analysis Revenue by Companies
3.4 Top 3 and Top 5 Cancer Genome Analysis Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Genome Analysis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Genome Analysis Players in Global Market
3.6.1 List of Global Tier 1 Cancer Genome Analysis Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Genome Analysis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Genome Analysis Market Size Markets, 2022 & 2030
4.1.2 Solid Tissue Analysis
4.1.3 Liquid Tissue Analysis
4.2 By Type - Global Cancer Genome Analysis Revenue & Forecasts
4.2.1 By Type - Global Cancer Genome Analysis Revenue, 2018-2023
4.2.2 By Type - Global Cancer Genome Analysis Revenue, 2024-2030
4.2.3 By Type - Global Cancer Genome Analysis Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Genome Analysis Market Size, 2022 & 2030
5.1.2 Clinical
5.1.3 Pharmaceutical
5.1.4 Research
5.2 By Application - Global Cancer Genome Analysis Revenue & Forecasts
5.2.1 By Application - Global Cancer Genome Analysis Revenue, 2018-2023
5.2.2 By Application - Global Cancer Genome Analysis Revenue, 2024-2030
5.2.3 By Application - Global Cancer Genome Analysis Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cancer Genome Analysis Market Size, 2022 & 2030
6.2 By Region - Global Cancer Genome Analysis Revenue & Forecasts
6.2.1 By Region - Global Cancer Genome Analysis Revenue, 2018-2023
6.2.2 By Region - Global Cancer Genome Analysis Revenue, 2024-2030
6.2.3 By Region - Global Cancer Genome Analysis Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cancer Genome Analysis Revenue, 2018-2030
6.3.2 US Cancer Genome Analysis Market Size, 2018-2030
6.3.3 Canada Cancer Genome Analysis Market Size, 2018-2030
6.3.4 Mexico Cancer Genome Analysis Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cancer Genome Analysis Revenue, 2018-2030
6.4.2 Germany Cancer Genome Analysis Market Size, 2018-2030
6.4.3 France Cancer Genome Analysis Market Size, 2018-2030
6.4.4 U.K. Cancer Genome Analysis Market Size, 2018-2030
6.4.5 Italy Cancer Genome Analysis Market Size, 2018-2030
6.4.6 Russia Cancer Genome Analysis Market Size, 2018-2030
6.4.7 Nordic Countries Cancer Genome Analysis Market Size, 2018-2030
6.4.8 Benelux Cancer Genome Analysis Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cancer Genome Analysis Revenue, 2018-2030
6.5.2 China Cancer Genome Analysis Market Size, 2018-2030
6.5.3 Japan Cancer Genome Analysis Market Size, 2018-2030
6.5.4 South Korea Cancer Genome Analysis Market Size, 2018-2030
6.5.5 Southeast Asia Cancer Genome Analysis Market Size, 2018-2030
6.5.6 India Cancer Genome Analysis Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cancer Genome Analysis Revenue, 2018-2030
6.6.2 Brazil Cancer Genome Analysis Market Size, 2018-2030
6.6.3 Argentina Cancer Genome Analysis Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Genome Analysis Revenue, 2018-2030
6.7.2 Turkey Cancer Genome Analysis Market Size, 2018-2030
6.7.3 Israel Cancer Genome Analysis Market Size, 2018-2030
6.7.4 Saudi Arabia Cancer Genome Analysis Market Size, 2018-2030
6.7.5 UAE Cancer Genome Analysis Market Size, 2018-2030
7 Cancer Genome Analysis Companies Profiles
7.1 Abbott Diagnostics
7.1.1 Abbott Diagnostics Company Summary
7.1.2 Abbott Diagnostics Business Overview
7.1.3 Abbott Diagnostics Cancer Genome Analysis Major Product Offerings
7.1.4 Abbott Diagnostics Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.1.5 Abbott Diagnostics Key News & Latest Developments
7.2 AccuraGen Inc
7.2.1 AccuraGen Inc Company Summary
7.2.2 AccuraGen Inc Business Overview
7.2.3 AccuraGen Inc Cancer Genome Analysis Major Product Offerings
7.2.4 AccuraGen Inc Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.2.5 AccuraGen Inc Key News & Latest Developments
7.3 Acuamark Diagnostics
7.3.1 Acuamark Diagnostics Company Summary
7.3.2 Acuamark Diagnostics Business Overview
7.3.3 Acuamark Diagnostics Cancer Genome Analysis Major Product Offerings
7.3.4 Acuamark Diagnostics Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.3.5 Acuamark Diagnostics Key News & Latest Developments
7.4 Admera Health, LLC
7.4.1 Admera Health, LLC Company Summary
7.4.2 Admera Health, LLC Business Overview
7.4.3 Admera Health, LLC Cancer Genome Analysis Major Product Offerings
7.4.4 Admera Health, LLC Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.4.5 Admera Health, LLC Key News & Latest Developments
7.5 Agena Bioscience, Inc
7.5.1 Agena Bioscience, Inc Company Summary
7.5.2 Agena Bioscience, Inc Business Overview
7.5.3 Agena Bioscience, Inc Cancer Genome Analysis Major Product Offerings
7.5.4 Agena Bioscience, Inc Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.5.5 Agena Bioscience, Inc Key News & Latest Developments
7.6 Agilent
7.6.1 Agilent Company Summary
7.6.2 Agilent Business Overview
7.6.3 Agilent Cancer Genome Analysis Major Product Offerings
7.6.4 Agilent Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.6.5 Agilent Key News & Latest Developments
7.7 Almac Diagnostics
7.7.1 Almac Diagnostics Company Summary
7.7.2 Almac Diagnostics Business Overview
7.7.3 Almac Diagnostics Cancer Genome Analysis Major Product Offerings
7.7.4 Almac Diagnostics Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.7.5 Almac Diagnostics Key News & Latest Developments
7.8 Amoy Diagnostics Co., Ltd.
7.8.1 Amoy Diagnostics Co., Ltd. Company Summary
7.8.2 Amoy Diagnostics Co., Ltd. Business Overview
7.8.3 Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Major Product Offerings
7.8.4 Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.8.5 Amoy Diagnostics Co., Ltd. Key News & Latest Developments
7.9 Anchor Dx
7.9.1 Anchor Dx Company Summary
7.9.2 Anchor Dx Business Overview
7.9.3 Anchor Dx Cancer Genome Analysis Major Product Offerings
7.9.4 Anchor Dx Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.9.5 Anchor Dx Key News & Latest Developments
7.10 ANGLE plc
7.10.1 ANGLE plc Company Summary
7.10.2 ANGLE plc Business Overview
7.10.3 ANGLE plc Cancer Genome Analysis Major Product Offerings
7.10.4 ANGLE plc Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.10.5 ANGLE plc Key News & Latest Developments
7.11 ApoCell, Inc.
7.11.1 ApoCell, Inc. Company Summary
7.11.2 ApoCell, Inc. Business Overview
7.11.3 ApoCell, Inc. Cancer Genome Analysis Major Product Offerings
7.11.4 ApoCell, Inc. Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.11.5 ApoCell, Inc. Key News & Latest Developments
7.12 ArcherDx, Inc
7.12.1 ArcherDx, Inc Company Summary
7.12.2 ArcherDx, Inc Business Overview
7.12.3 ArcherDx, Inc Cancer Genome Analysis Major Product Offerings
7.12.4 ArcherDx, Inc Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.12.5 ArcherDx, Inc Key News & Latest Developments
7.13 Asuragen
7.13.1 Asuragen Company Summary
7.13.2 Asuragen Business Overview
7.13.3 Asuragen Cancer Genome Analysis Major Product Offerings
7.13.4 Asuragen Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.13.5 Asuragen Key News & Latest Developments
7.14 AVIVA Biosciences
7.14.1 AVIVA Biosciences Company Summary
7.14.2 AVIVA Biosciences Business Overview
7.14.3 AVIVA Biosciences Cancer Genome Analysis Major Product Offerings
7.14.4 AVIVA Biosciences Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.14.5 AVIVA Biosciences Key News & Latest Developments
7.15 Baylor Miraca Genetics Laboratories
7.15.1 Baylor Miraca Genetics Laboratories Company Summary
7.15.2 Baylor Miraca Genetics Laboratories Business Overview
7.15.3 Baylor Miraca Genetics Laboratories Cancer Genome Analysis Major Product Offerings
7.15.4 Baylor Miraca Genetics Laboratories Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.15.5 Baylor Miraca Genetics Laboratories Key News & Latest Developments
7.16 Beckman Coulter, Inc.
7.16.1 Beckman Coulter, Inc. Company Summary
7.16.2 Beckman Coulter, Inc. Business Overview
7.16.3 Beckman Coulter, Inc. Cancer Genome Analysis Major Product Offerings
7.16.4 Beckman Coulter, Inc. Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.16.5 Beckman Coulter, Inc. Key News & Latest Developments
7.17 Becton, Dickinson and Company
7.17.1 Becton, Dickinson and Company Company Summary
7.17.2 Becton, Dickinson and Company Business Overview
7.17.3 Becton, Dickinson and Company Cancer Genome Analysis Major Product Offerings
7.17.4 Becton, Dickinson and Company Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.17.5 Becton, Dickinson and Company Key News & Latest Developments
7.18 BGI Genomics Co. Ltd
7.18.1 BGI Genomics Co. Ltd Company Summary
7.18.2 BGI Genomics Co. Ltd Business Overview
7.18.3 BGI Genomics Co. Ltd Cancer Genome Analysis Major Product Offerings
7.18.4 BGI Genomics Co. Ltd Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.18.5 BGI Genomics Co. Ltd Key News & Latest Developments
7.19 Bioarray Genetics
7.19.1 Bioarray Genetics Company Summary
7.19.2 Bioarray Genetics Business Overview
7.19.3 Bioarray Genetics Cancer Genome Analysis Major Product Offerings
7.19.4 Bioarray Genetics Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.19.5 Bioarray Genetics Key News & Latest Developments
7.20 Biocartis
7.20.1 Biocartis Company Summary
7.20.2 Biocartis Business Overview
7.20.3 Biocartis Cancer Genome Analysis Major Product Offerings
7.20.4 Biocartis Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.20.5 Biocartis Key News & Latest Developments
7.21 Biocept, Inc
7.21.1 Biocept, Inc Company Summary
7.21.2 Biocept, Inc Business Overview
7.21.3 Biocept, Inc Cancer Genome Analysis Major Product Offerings
7.21.4 Biocept, Inc Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.21.5 Biocept, Inc Key News & Latest Developments
7.22 Biodesix Inc
7.22.1 Biodesix Inc Company Summary
7.22.2 Biodesix Inc Business Overview
7.22.3 Biodesix Inc Cancer Genome Analysis Major Product Offerings
7.22.4 Biodesix Inc Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.22.5 Biodesix Inc Key News & Latest Developments
7.23 BioFluidica
7.23.1 BioFluidica Company Summary
7.23.2 BioFluidica Business Overview
7.23.3 BioFluidica Cancer Genome Analysis Major Product Offerings
7.23.4 BioFluidica Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.23.5 BioFluidica Key News & Latest Developments
7.24 bioM?rieux Diagnostics
7.24.1 bioM?rieux Diagnostics Company Summary
7.24.2 bioM?rieux Diagnostics Business Overview
7.24.3 bioM?rieux Diagnostics Cancer Genome Analysis Major Product Offerings
7.24.4 bioM?rieux Diagnostics Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.24.5 bioM?rieux Diagnostics Key News & Latest Developments
7.25 Bioneer Corporation
7.25.1 Bioneer Corporation Company Summary
7.25.2 Bioneer Corporation Business Overview
7.25.3 Bioneer Corporation Cancer Genome Analysis Major Product Offerings
7.25.4 Bioneer Corporation Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.25.5 Bioneer Corporation Key News & Latest Developments
7.26 Bio-Rad Laboratories, Inc
7.26.1 Bio-Rad Laboratories, Inc Company Summary
7.26.2 Bio-Rad Laboratories, Inc Business Overview
7.26.3 Bio-Rad Laboratories, Inc Cancer Genome Analysis Major Product Offerings
7.26.4 Bio-Rad Laboratories, Inc Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.26.5 Bio-Rad Laboratories, Inc Key News & Latest Developments
7.27 Bio-Techne
7.27.1 Bio-Techne Company Summary
7.27.2 Bio-Techne Business Overview
7.27.3 Bio-Techne Cancer Genome Analysis Major Product Offerings
7.27.4 Bio-Techne Cancer Genome Analysis Revenue in Global Market (2018-2023)
7.27.5 Bio-Techne Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Genome Analysis Market Opportunities & Trends in Global Market
Table 2. Cancer Genome Analysis Market Drivers in Global Market
Table 3. Cancer Genome Analysis Market Restraints in Global Market
Table 4. Key Players of Cancer Genome Analysis in Global Market
Table 5. Top Cancer Genome Analysis Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Genome Analysis Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Genome Analysis Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Genome Analysis Product Type
Table 9. List of Global Tier 1 Cancer Genome Analysis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Genome Analysis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Genome Analysis Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Cancer Genome Analysis Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Genome Analysis Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Cancer Genome Analysis Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Cancer Genome Analysis Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Genome Analysis Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Cancer Genome Analysis Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Cancer Genome Analysis Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Genome Analysis Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Cancer Genome Analysis Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Genome Analysis Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Cancer Genome Analysis Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Genome Analysis Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Cancer Genome Analysis Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Genome Analysis Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Cancer Genome Analysis Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Genome Analysis Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Cancer Genome Analysis Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Genome Analysis Revenue, (US$, Mn), 2024-2030
Table 30. Abbott Diagnostics Company Summary
Table 31. Abbott Diagnostics Cancer Genome Analysis Product Offerings
Table 32. Abbott Diagnostics Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Diagnostics Key News & Latest Developments
Table 34. AccuraGen Inc Company Summary
Table 35. AccuraGen Inc Cancer Genome Analysis Product Offerings
Table 36. AccuraGen Inc Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 37. AccuraGen Inc Key News & Latest Developments
Table 38. Acuamark Diagnostics Company Summary
Table 39. Acuamark Diagnostics Cancer Genome Analysis Product Offerings
Table 40. Acuamark Diagnostics Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 41. Acuamark Diagnostics Key News & Latest Developments
Table 42. Admera Health, LLC Company Summary
Table 43. Admera Health, LLC Cancer Genome Analysis Product Offerings
Table 44. Admera Health, LLC Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 45. Admera Health, LLC Key News & Latest Developments
Table 46. Agena Bioscience, Inc Company Summary
Table 47. Agena Bioscience, Inc Cancer Genome Analysis Product Offerings
Table 48. Agena Bioscience, Inc Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 49. Agena Bioscience, Inc Key News & Latest Developments
Table 50. Agilent Company Summary
Table 51. Agilent Cancer Genome Analysis Product Offerings
Table 52. Agilent Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 53. Agilent Key News & Latest Developments
Table 54. Almac Diagnostics Company Summary
Table 55. Almac Diagnostics Cancer Genome Analysis Product Offerings
Table 56. Almac Diagnostics Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 57. Almac Diagnostics Key News & Latest Developments
Table 58. Amoy Diagnostics Co., Ltd. Company Summary
Table 59. Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Product Offerings
Table 60. Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 61. Amoy Diagnostics Co., Ltd. Key News & Latest Developments
Table 62. Anchor Dx Company Summary
Table 63. Anchor Dx Cancer Genome Analysis Product Offerings
Table 64. Anchor Dx Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 65. Anchor Dx Key News & Latest Developments
Table 66. ANGLE plc Company Summary
Table 67. ANGLE plc Cancer Genome Analysis Product Offerings
Table 68. ANGLE plc Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 69. ANGLE plc Key News & Latest Developments
Table 70. ApoCell, Inc. Company Summary
Table 71. ApoCell, Inc. Cancer Genome Analysis Product Offerings
Table 72. ApoCell, Inc. Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 73. ApoCell, Inc. Key News & Latest Developments
Table 74. ArcherDx, Inc Company Summary
Table 75. ArcherDx, Inc Cancer Genome Analysis Product Offerings
Table 76. ArcherDx, Inc Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 77. ArcherDx, Inc Key News & Latest Developments
Table 78. Asuragen Company Summary
Table 79. Asuragen Cancer Genome Analysis Product Offerings
Table 80. Asuragen Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 81. Asuragen Key News & Latest Developments
Table 82. AVIVA Biosciences Company Summary
Table 83. AVIVA Biosciences Cancer Genome Analysis Product Offerings
Table 84. AVIVA Biosciences Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 85. AVIVA Biosciences Key News & Latest Developments
Table 86. Baylor Miraca Genetics Laboratories Company Summary
Table 87. Baylor Miraca Genetics Laboratories Cancer Genome Analysis Product Offerings
Table 88. Baylor Miraca Genetics Laboratories Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 89. Baylor Miraca Genetics Laboratories Key News & Latest Developments
Table 90. Beckman Coulter, Inc. Company Summary
Table 91. Beckman Coulter, Inc. Cancer Genome Analysis Product Offerings
Table 92. Beckman Coulter, Inc. Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 93. Beckman Coulter, Inc. Key News & Latest Developments
Table 94. Becton, Dickinson and Company Company Summary
Table 95. Becton, Dickinson and Company Cancer Genome Analysis Product Offerings
Table 96. Becton, Dickinson and Company Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 97. Becton, Dickinson and Company Key News & Latest Developments
Table 98. BGI Genomics Co. Ltd Company Summary
Table 99. BGI Genomics Co. Ltd Cancer Genome Analysis Product Offerings
Table 100. BGI Genomics Co. Ltd Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 101. BGI Genomics Co. Ltd Key News & Latest Developments
Table 102. Bioarray Genetics Company Summary
Table 103. Bioarray Genetics Cancer Genome Analysis Product Offerings
Table 104. Bioarray Genetics Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 105. Bioarray Genetics Key News & Latest Developments
Table 106. Biocartis Company Summary
Table 107. Biocartis Cancer Genome Analysis Product Offerings
Table 108. Biocartis Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 109. Biocartis Key News & Latest Developments
Table 110. Biocept, Inc Company Summary
Table 111. Biocept, Inc Cancer Genome Analysis Product Offerings
Table 112. Biocept, Inc Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 113. Biocept, Inc Key News & Latest Developments
Table 114. Biodesix Inc Company Summary
Table 115. Biodesix Inc Cancer Genome Analysis Product Offerings
Table 116. Biodesix Inc Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 117. Biodesix Inc Key News & Latest Developments
Table 118. BioFluidica Company Summary
Table 119. BioFluidica Cancer Genome Analysis Product Offerings
Table 120. BioFluidica Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 121. BioFluidica Key News & Latest Developments
Table 122. bioM?rieux Diagnostics Company Summary
Table 123. bioM?rieux Diagnostics Cancer Genome Analysis Product Offerings
Table 124. bioM?rieux Diagnostics Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 125. bioM?rieux Diagnostics Key News & Latest Developments
Table 126. Bioneer Corporation Company Summary
Table 127. Bioneer Corporation Cancer Genome Analysis Product Offerings
Table 128. Bioneer Corporation Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 129. Bioneer Corporation Key News & Latest Developments
Table 130. Bio-Rad Laboratories, Inc Company Summary
Table 131. Bio-Rad Laboratories, Inc Cancer Genome Analysis Product Offerings
Table 132. Bio-Rad Laboratories, Inc Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 133. Bio-Rad Laboratories, Inc Key News & Latest Developments
Table 134. Bio-Techne Company Summary
Table 135. Bio-Techne Cancer Genome Analysis Product Offerings
Table 136. Bio-Techne Cancer Genome Analysis Revenue (US$, Mn) & (2018-2023)
Table 137. Bio-Techne Key News & Latest Developments
List of Figures
Figure 1. Cancer Genome Analysis Segment by Type in 2022
Figure 2. Cancer Genome Analysis Segment by Application in 2022
Figure 3. Global Cancer Genome Analysis Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Genome Analysis Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Cancer Genome Analysis Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Genome Analysis Revenue in 2022
Figure 8. By Type - Global Cancer Genome Analysis Revenue Market Share, 2018-2030
Figure 9. By Application - Global Cancer Genome Analysis Revenue Market Share, 2018-2030
Figure 10. By Type - Global Cancer Genome Analysis Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Cancer Genome Analysis Revenue Market Share, 2018-2030
Figure 12. By Application - Global Cancer Genome Analysis Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Cancer Genome Analysis Revenue Market Share, 2018-2030
Figure 14. By Region - Global Cancer Genome Analysis Revenue Market Share, 2018-2030
Figure 15. By Country - North America Cancer Genome Analysis Revenue Market Share, 2018-2030
Figure 16. US Cancer Genome Analysis Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Cancer Genome Analysis Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Cancer Genome Analysis Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Cancer Genome Analysis Revenue Market Share, 2018-2030
Figure 20. Germany Cancer Genome Analysis Revenue, (US$, Mn), 2018-2030
Figure 21. France Cancer Genome Analysis Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Cancer Genome Analysis Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Cancer Genome Analysis Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Cancer Genome Analysis Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Cancer Genome Analysis Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Cancer Genome Analysis Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Cancer Genome Analysis Revenue Market Share, 2018-2030
Figure 28. China Cancer Genome Analysis Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Cancer Genome Analysis Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Cancer Genome Analysis Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Cancer Genome Analysis Revenue, (US$, Mn), 2018-2030
Figure 32. India Cancer Genome Analysis Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Cancer Genome Analysis Revenue Market Share, 2018-2030
Figure 34. Brazil Cancer Genome Analysis Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Cancer Genome Analysis Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Cancer Genome Analysis Revenue Market Share, 2018-2030
Figure 37. Turkey Cancer Genome Analysis Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Cancer Genome Analysis Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Cancer Genome Analysis Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Cancer Genome Analysis Revenue, (US$, Mn), 2018-2030
Figure 41. Abbott Diagnostics Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AccuraGen Inc Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Acuamark Diagnostics Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Admera Health, LLC Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Agena Bioscience, Inc Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Agilent Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Almac Diagnostics Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Anchor Dx Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. ANGLE plc Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. ApoCell, Inc. Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. ArcherDx, Inc Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Asuragen Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. AVIVA Biosciences Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Baylor Miraca Genetics Laboratories Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Beckman Coulter, Inc. Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Becton, Dickinson and Company Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. BGI Genomics Co. Ltd Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Bioarray Genetics Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Biocartis Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Biocept, Inc Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Biodesix Inc Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. BioFluidica Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 64. bioM?rieux Diagnostics Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 65. Bioneer Corporation Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 66. Bio-Rad Laboratories, Inc Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 67. Bio-Techne Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
